These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
577 related items for PubMed ID: 27896799
1. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland. Moga DC, Taipale H, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D. Drugs Aging; 2017 Jan; 34(1):55-65. PubMed ID: 27896799 [Abstract] [Full Text] [Related]
2. Change in psychotropic drug use among community-dwelling people aged 75 years and older in Finland: repeated cross-sectional population studies. Desplenter F, Caenen C, Meelberghs J, Hartikainen S, Sulkava R, Bell JS. Int Psychogeriatr; 2011 Oct; 23(8):1278-84. PubMed ID: 21554797 [Abstract] [Full Text] [Related]
3. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study. Törmälehto S, Martikainen J, Bell JS, Hallikainen I, Koivisto AM. Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207 [Abstract] [Full Text] [Related]
4. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease. Orsel K, Taipale H, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S. Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953 [Abstract] [Full Text] [Related]
5. Drug use in persons with and without Alzheimer's disease aged 90 years or more. Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205 [Abstract] [Full Text] [Related]
6. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort. Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487 [Abstract] [Full Text] [Related]
7. Prevalence and appropriateness of psychotropic medication prescribing in a nationally representative cross-sectional survey of male and female prisoners in England. Hassan L, Senior J, Webb RT, Frisher M, Tully MP, While D, Shaw JJ. BMC Psychiatry; 2016 Oct 10; 16(1):346. PubMed ID: 27724879 [Abstract] [Full Text] [Related]
8. Sedative Load in Community-Dwelling Older Adults with Mild-Moderate Alzheimer's Disease: Longitudinal Relationships with Adverse Events, Delirium and Falls. Dyer AH, Murphy C, Lawlor B, Kennelly SP, NILVAD StudyGroup. Drugs Aging; 2020 Nov 10; 37(11):829-837. PubMed ID: 32924095 [Abstract] [Full Text] [Related]
9. Association among presence of cancer pain, inadequate pain control, and psychotropic drug use. Parás-Bravo P, Paz-Zulueta M, Alonso-Blanco MC, Salvadores-Fuentes P, Alconero-Camarero AR, Santibañez M. PLoS One; 2017 Nov 10; 12(6):e0178742. PubMed ID: 28594871 [Abstract] [Full Text] [Related]
10. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study. Tolppanen AM, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S. BMJ Open; 2016 Jul 13; 6(7):e012100. PubMed ID: 27412109 [Abstract] [Full Text] [Related]
17. Changes between 1982 and 2000 in the prevalence of behavioral symptoms and psychotropic drug treatment among old people with cognitive impairment in geriatric care. Lövheim H, Sandman PO, Karlsson S, Gustafson Y. Int Psychogeriatr; 2009 Oct 13; 21(5):941-8. PubMed ID: 19586566 [Abstract] [Full Text] [Related]
18. Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts. Ruths S, Sørensen PH, Kirkevold Ø, Husebø BS, Krüger K, Halvorsen KH, Selbaek G. Int J Geriatr Psychiatry; 2013 Aug 13; 28(8):868-76. PubMed ID: 23147389 [Abstract] [Full Text] [Related]